Polypharmakos Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $13.5M

Polypharmakos General Information

Description

Developer of a natural product discovery platform designed to identify compounds from plants and fungi that impact inflammatory pathways associated with aging. The company offers access to the world's largest verified libraries of plant and fungal extracts, enabling pharmaceuticals to discover and develop anti-inflammation and aging nutraceuticals and drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Saint John's Innovation Centre
  • Cowley Road, Milton
  • Cambridge CB4 0WS
  • England, United Kingdom
+44 07831
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Saint John's Innovation Centre
  • Cowley Road, Milton
  • Cambridge CB4 0WS
  • England, United Kingdom
+44 07831

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Polypharmakos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) $13.5M Completed Generating Revenue
3. Secondary Transaction - Private 28-Feb-2023 Completed Generating Revenue
2. Early Stage VC 30-Jan-2017 $742K $742K Completed Generating Revenue
1. University Spin-Out 16-Mar-2016 Completed Generating Revenue
To view Polypharmakos’s complete valuation and funding history, request access »

Polypharmakos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Polypharmakos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Polypharmakos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Polypharmakos FAQs

  • When was Polypharmakos founded?

    Polypharmakos was founded in 2016.

  • Where is Polypharmakos headquartered?

    Polypharmakos is headquartered in Cambridge, United Kingdom.

  • What is the size of Polypharmakos?

    Polypharmakos has 4 total employees.

  • What industry is Polypharmakos in?

    Polypharmakos’s primary industry is Drug Discovery.

  • Is Polypharmakos a private or public company?

    Polypharmakos is a Private company.

  • What is Polypharmakos’s current revenue?

    The current revenue for Polypharmakos is .

  • How much funding has Polypharmakos raised over time?

    Polypharmakos has raised $14.2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process